Advertisement
Advertisement

LFCR

LFCR logo

Lifecore Biomedical, Inc. Common Stock

8.69
USD
Sponsored
+0.18
+2.15%
Jan 30, 16:00 UTC -5
Closed
exchange

Pre-Market

8.69

0.00
-0.06%

LFCR Earnings Reports

Positive Surprise Ratio

LFCR beat 20 of 35 last estimates.

57%

Next Report

Date of Next Report
Apr 01, 2026
Estimate for Q3 26 (Revenue/ EPS)
$32.20M
/
-$0.22
Implied change from Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
-8.41%
/
-53.19%

Lifecore Biomedical, Inc. Common Stock earnings per share and revenue

On Jan 02, 2026, LFCR reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -0.19 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 32.99 million, with a --% difference.
Looking ahead to Q3 26, 7 analysts forecast an EPS of -0.22 USD, with revenue projected to reach 32.20 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Twist Bioscience Corporation Common Stock
Report Date
Feb 02, 2026 For Q1 26
Estimate
-$0.43
Actual
-$0.50
Surprise
-14.00%
FAQ
For Q2 2026, Lifecore Biomedical, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Apr 01, 2026.
Based on 7 analysts, Lifecore Biomedical, Inc. Common Stock is expected to report EPS of -$0.22 and revenue of $32.20M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement